Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target corresponds to a **unitary pseudogene**, meaning it is a segment of DNA that shares sequence similarity with a putative or hypothetical protein (in this case, “novel protein DKFZP434H132”) but has lost the ability to code for a functional protein due to mutations or other inactivating changes[7]. Unitary pseudogenes occasionally possess regulatory functions as non-coding RNAs, such as acting as “microRNA sponges” or engaging in RNA-mediated gene regulation, but the vast majority, including this entry, have no documented function and are not considered therapeutic targets[1][6][7]. There are no known associated drugs or roles in disease, nor is it used as a biomarker. The precise biological or clinical relevance of ENSG00000227994 is, as of current literature, unestablished.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of novel protein DKFZP434H132 (ENSG00000227994).